Changing Diabetes Barometer
At the Global Changing Diabetes® Leadership Forum on 13-14 March 2007 in New York City, Lars Rebien Sørensen, president and CEO of Novo Nordisk, announced that the company’s intention to launch an initiative called the Changing Diabetes® Barometer.
Launched later that year, the initiative seeks to establish the level of measurability necessary in order to track and guide improvements in diabetes care.
A crucial driver of improving diabetes care is the continuous measurement of the status of prevention, progress and treatment of diabetes at an international, national, regional and local level across countries. The initiative encourages and promotes the collecting and sharing of that information to identify both best practices and areas for improvement, and the application of this knowledge to improve patient outcomes. ‘Constructive competition’ will then be enabled which will drive up standards.
The first international Changing Diabetes® Barometer report was published on 7 November 2007 and launched in Brussels to an audience of politicians, patients, patient organisations, doctors and journalists.
However, the Changing Diabetes® Barometer is about more than ‘just data’; it is about telling stories with information. The stories behind diabetes data link the raw numbers to the hard outcomes, and these outcomes to the human beings whose lives we, Novo Nordisk and all involved in diabetes research and care, are trying to improve by changing diabetes.
We look forward to working with our partners around the world to measure the progression of diabetes, share this information, and spread best practices that can improve outcomes and quality of life for people with diabetes. This is the core of changing diabetes; it is our duty, our commitment, and our business.
For further information on the Changing Diabetes® Barometer, please see this background document and the press release.
